Device-tax repeal will keep U.S. edge in global medtech, exec says

03/27/2013 | Hill, The

The industry already has paid the Internal Revenue Service about $388 million since the 2.3% medical device tax went into effect in January, shifting funds that could be used to create jobs and advance research and development, writes Siemens Healthcare CEO Dr. Greg Sorensen. The passage of the Senate budget amendment to repeal the tax is a key step toward reversing its adverse effects and preserving U.S. leadership in the global medtech industry, he writes.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ